Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from HitIQ Limited ( (AU:HIQ) ).
HITIQ Limited has completed the initial tranche of a placement, raising $900,000 before costs by issuing 40,909,092 ordinary shares at $0.022 each. The placement also includes one new listed option for every two shares, exercisable at $0.022 and expiring on 30 December 2028. Directors Tony Toohey and James Barrie have participated in the placement, with their involvement pending shareholder approval in January 2026. This development aligns with HITIQ’s ongoing efforts to strengthen its financial position and support its concussion management technology initiatives.
The most recent analyst rating on (AU:HIQ) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
More about HitIQ Limited
HITIQ Limited (ASX: HIQ) is a company specializing in concussion management technology, offering smart mouthguards and software for sports, clinical, and research applications globally. Their PROTEQT™ system is designed to enhance athlete safety across both elite and community sports.
Average Trading Volume: 672,796
Technical Sentiment Signal: Sell
Current Market Cap: A$11.21M
See more insights into HIQ stock on TipRanks’ Stock Analysis page.